The indispensable function of IFNγ in CAR T cell therapy targeting solid tumors has also been demonstrated by Larson et al, who conducted a genome-wide CRISPR knockout screen in glioblastoma and found that the knout out of genes in the IFNγ receptor signaling pathway (e. The gene discussed is IFNG; the disease is glioblastoma.